==== Forms & Identification ====
2,5-DMA is exceptionally rare on contemporary markets. Any material encountered is likely of research-chemical origin with no quality assurance. Given the compound's high [[glossary:active-dose]] (80–160 mg), it cannot fit on standard blotter paper — if sold as blotter, it is almost certainly mislabeled or a different, more potent substance.
[[glossary:reagent-kit|Reagent testing]] can confirm the presence of a methoxylated [[substance:amphetamine]] but cannot distinguish 2,5-DMA from its far more potent 4-substituted [[glossary:derivative|derivatives]] ([[substance:doi]], [[substance:dob]], [[substance:doc]], [[substance:dom]]). Quantitative analysis (GC-MS or comparable) is the only reliable identification method. Treat unverified material with extreme caution — [[effect:confusion]] with [[substance_class:chemical/dox]] compounds active at 1–5 mg could produce a dangerous [[glossary:overdose]] if dosed at 2,5-DMA levels.
==== Set & Setting ====
The experience is predominantly physical — cardiovascular [[effect:stimulation]] and [[effect:wakefulness]] without perceptual change. A calm, comfortable environment reduces the likelihood of [[substance_class:psychoactive/stimulant]]-associated [[effect:anxiety]]. The 6–8 hour duration means planning for a full day without obligations.
No psychological preparation for [[substance_class:psychoactive/psychedelic]]-type experiences is necessary, as the compound does not produce them. A [[glossary:sitter]] is less critical than with psychedelics but remains advisable given the unknown [[glossary:toxicity|toxicity profile]] and [[glossary:sympathomimetic]] load.
{{Guideline}}
==== Guidelines ====
* Test all material with reagent kits AND quantitative analysis where possible — reagents alone cannot distinguish 2,5-DMA from far more potent DOx compounds
* Weigh doses with a milligram-precision scale; volumetric dosing is acceptable for solutions
* Start at the low end of the active range and wait at least 2 hours before considering [[glossary:redose|redosing]]
* Monitor [[glossary:heart-rate]]; if resting heart rate exceeds 120 bpm or chest discomfort develops, do not redose
* Ensure adequate [[glossary:hydration]] throughout the experience
* Avoid [[glossary:physical-exertion]] that compounds cardiovascular strain
* Do not combine with other stimulants, serotonergic substances, or MAOIs
{{/Guideline}}
{{Emergency}}
==== Emergency Response ====
'''Recognizing an emergency:'''
* [[glossary:chest-pain]] or pressure
* Heart rate above 150 bpm or irregular heartbeat
* Severe [[effect:headache]] with visual [[glossary:disturbance]] (possible [[glossary:blood-pressure]] crisis)
* [[glossary:body-temperature]] high enough to feel through clothing
* [[glossary:seizure]] or [[glossary:loss-of-consciousness]]
* Severe [[glossary:agitation]] unresponsive to [[glossary:reassurance]]
'''Immediate steps:'''
* Call emergency services if any of the above are present
* Move the person to a cool, quiet environment
* Remove excess clothing if body temperature is elevated
* Do not induce [[effect:vomiting]]
* If unconscious but breathing, place in the [[glossary:recovery-position]]
* Monitor breathing and pulse until help arrives
'''What to tell the dispatcher:'''
Name the substance (2,5-DMA or dimethoxyamphetamine), approximate amount taken, time of [[glossary:ingestion]], and current symptoms. [[glossary:good-samaritan-law|Good Samaritan laws]] in many jurisdictions protect callers from drug-related [[glossary:prosecution]].
No specific reversal agent exists for sympathomimetic toxicity. Hospital treatment is supportive: cooling, blood pressure management, and [[effect:sedation]] with [[substance_class:chemical/benzodiazepine|benzodiazepines]] if needed.
{{/Emergency}}
{{Aftercare}}
==== Aftercare & Integration ====
The comedown from 2,5-DMA resembles that of other stimulants — [[glossary:fatigue]], mild low mood, and difficulty sleeping may follow. Prioritize sleep recovery: a dark, quiet environment and avoidance of additional stimulants (including [[substance:caffeine]]) in the 12 hours following the experience.
Nutrition and hydration support recovery. Light meals during and after the experience help offset the [[effect:appetite-suppression]] common to sympathomimetic compounds. No psychological [[glossary:integration]] in the psychedelic sense is typically needed, as the experience does not produce meaningful perceptual or cognitive alteration.
{{/Aftercare}}
{{Recovery}}
==== Recovery & Support ====
2,5-DMA does not produce [[glossary:physical-dependence]] or [[glossary:withdrawal]]. Compulsive use patterns have not been documented for this compound. If stimulant use of any kind has become problematic, general stimulant recovery resources apply — including SMART Recovery, local [[glossary:addiction]] services, and [[glossary:peer-support]] communities. Seek professional support if use of stimulants is interfering with daily functioning, relationships, or health.
{{/Recovery}}